Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $9.40 Analyst target: $49.57 Upside: 427.34%
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company is headquartered in Durham, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.